Fig. 4.
Fig. 4. Allogeneic cytotoxicity of granzyme B−/− × gld/gld CTLs against three different tumor cell lines. H-2b anti–H-2d CTLs produced in day 5 MCR cultures from granzyme B+/+ (B+/+), granzyme B−/− (B−/−), and granzyme B−/− × gld/gld (B−/− × g/g) spleens were tested against TA3 (A and B), P815 (C and D), and YAC-1 (E and F) cells at varying E:T ratios after 10 hours of incubation in a 51Cr release (A, C, and E) and 125IUdR release (B, D, and F) assays. All three types of effector cells induce similar levels of 51Cr release from TA3, P815, or YAC-1 targets. Granzyme B−/− × gld/gld CTLs exhibit reduced amounts of 125I-labeled DNA release at all E:T ratios tested against all three lines.

Allogeneic cytotoxicity of granzyme B−/− × gld/gld CTLs against three different tumor cell lines. H-2b anti–H-2d CTLs produced in day 5 MCR cultures from granzyme B+/+ (B+/+), granzyme B−/− (B−/−), and granzyme B−/− × gld/gld (B−/− × g/g) spleens were tested against TA3 (A and B), P815 (C and D), and YAC-1 (E and F) cells at varying E:T ratios after 10 hours of incubation in a 51Cr release (A, C, and E) and 125IUdR release (B, D, and F) assays. All three types of effector cells induce similar levels of 51Cr release from TA3, P815, or YAC-1 targets. Granzyme B−/− × gld/gld CTLs exhibit reduced amounts of 125I-labeled DNA release at all E:T ratios tested against all three lines.

Close Modal

or Create an Account

Close Modal
Close Modal